Lōkahi Therapeutics™ Advances LT-100 Development Strategy Toward Single-Injection Administration

Go back to Lōkahi Therapeutics™ Advances LT-100 Development Strategy Toward Single-Injection Administration
(NASDAQ: GCTK) Delayed: 2.30 +0.06 (2.68%)
Previous Close $2.24    52 Week High
Open $2.28    52 Week Low
Day High $2.30    P/E N/A 
Day Low $2.24    EPS
Volume 9,643